191 related articles for article (PubMed ID: 10026401)
1. Percutaneous absorption of salicylic acid in man after topical administration of three different formulations.
Schwarb FP; Gabard B; Rufli T; Surber C
Dermatology; 1999; 198(1):44-51. PubMed ID: 10026401
[TBL] [Abstract][Full Text] [Related]
2. Distribution of salicylic acid in human stratum corneum following topical application in vivo: a comparison of six different formulations.
Tsai J; Chuang S; Hsu M; Sheu H
Int J Pharm; 1999 Oct; 188(2):145-53. PubMed ID: 10518670
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of skin penetration of topically applied drugs in humans by cutaneous microdialysis: acyclovir vs. salicylic acid.
Klimowicz A; Farfał S; Bielecka-Grzela S
J Clin Pharm Ther; 2007 Apr; 32(2):143-8. PubMed ID: 17381664
[TBL] [Abstract][Full Text] [Related]
4. Effect of ointment bases on topical and transdermal delivery of salicylic acid in rats: evaluation by skin microdialysis.
Murakami T; Yoshioka M; Okamoto I; Yumoto R; Higashi Y; Okahara K; Yata N
J Pharm Pharmacol; 1998 Jan; 50(1):55-61. PubMed ID: 9504435
[TBL] [Abstract][Full Text] [Related]
5. In vivo microdialysis for the investigation of drug levels in the dermis and the effect of barrier perturbation on cutaneous drug penetration. Studies in hairless rats and human subjects.
Benfeldt E
Acta Derm Venereol Suppl (Stockh); 1999; 206():1-59. PubMed ID: 10605601
[TBL] [Abstract][Full Text] [Related]
6. Studies on the metabolism and disposition of the new retinoid 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)carbamoyl]benzoic acid. 5th communication: factors affecting percutaneous absorption in rats.
Mizojiri K; Okabe H; Sugeno K; Esumi Y; Takaichi M; Okamura Y; Kashiwazaki K; Takahashi N
Arzneimittelforschung; 1997 Mar; 47(3):270-5. PubMed ID: 9105545
[TBL] [Abstract][Full Text] [Related]
7. Distribution and keratolytic effect of salicylic acid and urea in human skin.
Lodén M; Boström P; Kneczke M
Skin Pharmacol; 1995; 8(4):173-8. PubMed ID: 7488393
[TBL] [Abstract][Full Text] [Related]
8. Percutaneous penetration of octyl salicylate from representative sunscreen formulations through human skin in vitro.
Walters KA; Brain KR; Howes D; James VJ; Kraus AL; Teetsel NM; Toulon M; Watkinson AC; Gettings SD
Food Chem Toxicol; 1997 Dec; 35(12):1219-25. PubMed ID: 9449227
[TBL] [Abstract][Full Text] [Related]
9. Serum concentrations of salicylic acid following topically applied salicylate derivatives.
Morra P; Bartle WR; Walker SE; Lee SN; Bowles SK; Reeves RA
Ann Pharmacother; 1996 Sep; 30(9):935-40. PubMed ID: 8876850
[TBL] [Abstract][Full Text] [Related]
10. In vivo measurement of the keratolytic effect of salicylic acid in three ointment formulations.
Nook TH
Br J Dermatol; 1987 Aug; 117(2):243-5. PubMed ID: 3651343
[TBL] [Abstract][Full Text] [Related]
11. Effects of topical petrolatum and salicylic acid on the erythemogenicity of UVB.
Fetil E; Ozka S; Soyal MC; Ilknur T; Erdem Y; Güneş AT
Eur J Dermatol; 2002; 12(2):154-6. PubMed ID: 11872412
[TBL] [Abstract][Full Text] [Related]
12. Effects of mixing procedure itself on the structure, viscosity, and spreadability of white petrolatum and salicylic acid ointment and the skin permeation of salicylic acid.
Kitagawa S; Fujiwara M; Okinaka Y; Yutani R; Teraoka R
Chem Pharm Bull (Tokyo); 2015; 63(1):43-8. PubMed ID: 25400272
[TBL] [Abstract][Full Text] [Related]
13. [Transdermal salicylate absorption following epidermal application of an analgesic / antiphlogistic ointment and gel formulation (author's transl)].
Hüther KJ; Hiereth H; Messer W
Arzneimittelforschung; 1982; 32(1):69-72. PubMed ID: 7199343
[TBL] [Abstract][Full Text] [Related]
14. [Clinical effect of salicylic acid and high dose urea applied according to the standardized New German Formulary].
Gloor M; Fluhr J; Wasik B; Gehring W
Pharmazie; 2001 Oct; 56(10):810-4. PubMed ID: 11683130
[TBL] [Abstract][Full Text] [Related]
15. New formulation of chemical peeling agent: 30% salicylic acid in polyethylene glycol. Absorption and distribution of 14C-salicylic acid in polyethylene glycol applied topically to skin of hairless mice.
Ueda S; Mitsugi K; Ichige K; Yoshida K; Sakuma T; Ninomiya S; Sudou T
J Dermatol Sci; 2002 Apr; 28(3):211-8. PubMed ID: 11912008
[TBL] [Abstract][Full Text] [Related]
16. Photocarcinogenesis study of glycolic acid and salicylic acid (CAS Nos. 79-14-1 and 69-72-7) in SKH-1 mice (simulated solar light and topical application study).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 2007 Sep; (524):1-242. PubMed ID: 21921960
[TBL] [Abstract][Full Text] [Related]
17. Barrier function of intact and impaired skin: percutaneous penetration of caffeine and salicylic acid.
Rubio L; Alonso C; López O; Rodríguez G; Coderch L; Notario J; de la Maza A; Parra JL
Int J Dermatol; 2011 Jul; 50(7):881-9. PubMed ID: 21699529
[TBL] [Abstract][Full Text] [Related]
18. Relative bioavailability of salicylic acid following dermal application of a 30% salicylic acid skin peel preparation.
Fung W; Orak D; Re TA; Haughey DB
J Pharm Sci; 2008 Mar; 97(3):1325-8. PubMed ID: 17694544
[TBL] [Abstract][Full Text] [Related]
19. Rate and extent of percutaneous absorption of sertaconazole nitrate after topical administration.
Susilo R; Korting HC; Strauss UP; Menke G; Schuster O; Menke A
Arzneimittelforschung; 2005; 55(6):338-42. PubMed ID: 16032974
[TBL] [Abstract][Full Text] [Related]
20. Cutaneous bioassay of salicylic acid as a keratolytic.
Bashir SJ; Dreher F; Chew AL; Zhai H; Levin C; Stern R; Maibach HI
Int J Pharm; 2005 Mar; 292(1-2):187-94. PubMed ID: 15725565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
